Table 5 Differences in rheumatic disease with and without pulmonary involvement
Variables | Pulmonary involvement | Non-pulmonary involvement | P-value |
|---|---|---|---|
Age, mean ± SD (years) | 11.2 ± 2.5 | 11.6 ± 2.7 | 0.687 |
Female (%) | 22/31 (70.1) | 7/17 (41.2) | 0.044* |
Height (cm) | 143.0 ± 12.4 | 146.8 ± 12.6 | 0.314 |
Weight (kg) | 36.1 ± 11.1 | 41.8 ± 12.8 | 0.111 |
Illness 1(%)- SLE | 14 (45.2) | 2 (11.8) | 0.025* |
Illness 2 (%)- JIA | 7 (22.6) | 4 (23.5) | Â |
Illness 3 (%)- JDM | 4 (12.9) | 1 (5.9) | Â |
Illness 4 (%)- others | 6 (19.4) | 10 (58.8) | Â |
Disease duration, median [Q1, Q3] years | 0.25 [0.08, 0.62] | 0.58 [0.17, 1] | 0.275 |
Cigarette exposure (%) | 44.4 | 64.3 | 0.381 |
ESR, mean ± SD (mm/h) | 43.9 ± 31.9 | 21.5 ± 21.0 | 0.031* |
CRP > 8 mg/L (%) | 9/31 (29.0) | 2/17 (11.8) | 0.316 |
ANA ( +) (%) | 19/31 (61.3) | 10/17 (58.8) | 0.867 |
RF ( +) (%) | 3/31 (9.7) | 2/17 (11.8) | 0.789 |
CD4/CD8, mean ± SD | 1.4 ± 0.5 | 1.0 ± 0.5 | 0.026* |
Medication exposures | NO | NO | Â |